LONDON, Nov. 4, 2015 /PRNewswire/ -- Based on its recent analysis of the contrast autoinjectors market, Frost & Sullivan recognizes ulrich medical with the 2015 European Frost & Sullivan Award for Competitive Strategy Innovation and Leadership. ulrich medical's innovative autoinjector products have evolved as the first patented commercial units with roll pump technology for the delivery of contrast media during medical imaging diagnosis.
Photo - http://photos.prnewswire.com/prnh/20151104/283737
The unique patented design principle of the roll pump system in ulrich medical's autoinjector enables potential savings of costs of disposables and personnel compared to conventional double piston injectors or power injectors.
"ulrich medical's autoinjectors are the first ever commercial units that have had their hygiene levels certified by an independent test laboratory in Germany," said Frost & Sullivan Senior Research Analyst Srikanth Kompalli. "Additionally, the integrated pressure control system and sensors for the prevention of air injection involves a hose system that includes check valves and has a particle filter. This presents the user with complete control over injection of the contrast agent into the patient."
ulrich medical's products aid high performance and low consumption, as they can perform several injections from just one contrast media container with the help of the pump hose. This technology makes it possible to prepare the injector once daily for use, and considerably lessens the changeover-time between patients. Besides, the automatic filling of the patient hose with sodium chloride (NaCl) after each injection decreases the wastage of contrast media/agent while changing the patient hose.
"With ulrich medical's autoinjectors, the contrast agent and NaCl are supplied directly from the contrast agent manufacturer's container, and if a container gets emptied during the application procedure, the procedure is automatically continued from another container, without causing any wastage," noted Kompalli.
The autoinjector also boasts software and touch sensitivity. It employs inventive software for CT/MRI and angiography examinations, with a multitude of user-friendly and touch-terminal functions integrated into the respective imaging systems.
Krishna Srinivasan, Global President and Managing Partner, Frost & Sullivan sums up, "In a market characterized by generic solutions, the companies that thrive are the ones that are a step ahead of their competition. Frost & Sullivan is pleased to recognize ulrich medical for its innovative new product strategy that has helped strengthen its brand and competitive position in the contrast autoinjectors market."
Each year, Frost & Sullivan presents this award to the company that has leveraged competitive intelligence to successfully execute a competitive strategy that results in stronger market share, competitive brand positioning and customer satisfaction.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
About ulrich medical
ulrich medical develops, produces and markets innovative medical technology. Physicians and users worldwide trust our more than 100 years of experience. With product divisions in contrast medium injectors, spinal implants as well as surgical instruments and tourniquets, we offer a comprehensive portfolio of innovative products.
We are one of the few in the industry with development and production in Germany and we rely on the most modern manufacturing technology. Our products stand worldwide for the highest degree of quality "Made in Germany".
More than 280 employees work at the headquarters in Ulm. As an owner-run company, we operate independently and are proud of our continuous, healthy growth.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion
Subscribe: Newsletter on "the next big thing"
Register: Gain access to visionary innovation
Contact:
Ben Bauerschaper
Director Marketing
ulrich medical
Tel: +49-(0)-9654-120
Adelaide Mendes
Best Practices Group
Frost & Sullivan
Tel.: +44-(0)-207-9157869
E-mail: adelaide.mendes@frost.com
